SCHEMBL313151

SCHEMBL313151

O=C(O)c1c(CCc2cc3ccccc3c(C(=O)O)c2C(=O)O)cc2ccccc2c1C(=O)O

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.66
KMT2A Q03164 4/20 0.66
KDM4E B2RXH2 4/20 0.66
ALDH1A1 P00352 2/20 0.66
CYP1A2 P05177 1/20 0.66
GLA P06280 1/20 0.66
HPGD P15428 1/20 0.66
CYP2C19 P33261 1/20 0.66
HSD17B10 Q99714 1/20 0.66
ME2 P23368 1/20 0.54
ME1 P48163 1/20 0.54
ME3 Q16798 1/20 0.54
SOX18 P35713 1/20 0.44
GPR35 Q9HC97 2/20 0.44
POLB P06746 1/20 0.44
CDC25B P30305 2/20 0.42
RXFP1 Q9HBX9 1/20 0.42
TDP1 Q9NUW8 2/20 0.42
NR4A1 P22736 1/20 0.41
NR4A2 P43354 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28751492 0.91 MEN1 (0.59) MEN1KMT2AKDM4EALDH1A1CYP1A2
SCHEMBL897604 0.87 MEN1 (0.63) MEN1KMT2AKDM4EALDH1A1CYP1A2
SCHEMBL9250273 0.86 MEN1 (0.61) MEN1KMT2AKDM4EALDH1A1CYP1A2
SCHEMBL5575880 0.85 BID (0.54) MEN1KMT2AKDM4EALDH1A1CYP1A2
SCHEMBL7184877 0.85 BID (0.54) MEN1KMT2AKDM4EALDH1A1CYP1A2
SCHEMBL2880041 0.82 MEN1 (0.56) MEN1KMT2AKDM4EALDH1A1CYP1A2
SCHEMBL10409343 0.81 KDM4E (0.47) MEN1KMT2AKDM4EALDH1A1CYP1A2
SCHEMBL28051080 0.80 MEN1 (0.54) MEN1KMT2AKDM4EALDH1A1CYP1A2
SCHEMBL8415537 0.80 THRB (0.49) MEN1KMT2AKDM4EALDH1A1CYP1A2
SCHEMBL4731723 0.80 ME2 (0.73) MEN1KMT2AKDM4EALDH1A1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8384982-B2 Display element KONICA MINOLTA HOLDINGS, INC. (JP) 2013-02-26 US disclosed
EP-2189840-B1 DISPLAY ELEMENT KONICA MINOLTA HOLDINGS INC (JP) 2012-02-01 EP disclosed
US-8094360-B2 Room temperature molten salt and display element KONICA MINOLTA HOLDINGS, INC. (JP) 2012-01-10 US disclosed
US-8049948-B2 Process for producing electrochemical display element and electrochemical display element KONICA MINOLTA HOLDINGS, INC. (JP) 2011-11-01 US disclosed
EP-2056277-B1 DISPLAY ELEMENT KONICA MINOLTA HOLDINGS INC (JP) 2011-10-26 EP disclosed
US-8004742-B2 Electrochromic display device KONICA MINOLTA HOLDINGS, INC. (JP) 2011-08-23 US disclosed
US-7990606-B2 Display element KONICA MINOLTA HOLDINGS, INC. (JP) 2011-08-02 US disclosed
US-20110133192-A1 METHOD OF FORMING CONDUCTIVE PATTERN AND ORGANIC THIN FILM TRANSISTOR KONICA MINOLTA HOLDINGS, INC. (JP) 2011-06-09 US disclosed
US-20110058244-A1 ELECTROCHROMIC DISPLAY ELEMENT KONICA MINOLTA HOLDINGS, INC. (JP) 2011-03-10 US disclosed
EP-1887418-B1 METHOD OF MANUFACTURING A DISPLAY ELEMENT KONICA MINOLTA HOLDINGS INC (JP) 2010-09-22 EP disclosed
EP-2056277-A1 DISPLAY ELEMENT Konica Minolta Holdings, Inc. (JP) 2009-05-06 EP disclosed
US-7518777-B2 Display element KONICA MINOLTA HOLDINGS, INC. (JP) 2009-04-14 US disclosed
US-20090091234-A1 ROOM TEMPERATURE MOLTEN SALT AND DISPLAY ELEMENT KONICA MINOLTA HOLDINGS, INC. (JP) 2009-04-09 US disclosed
US-7479310-B2 Displaying medium KONICA MINOLTA HOLDINGS, INC. (JP) 2009-01-20 US disclosed
EP-1975692-A1 DISPLAY ELEMENT KONICA MINOLTA HOLDINGS, INC. (JP) 2008-10-01 EP disclosed
US-20080204849-A1 Display Element KONICA MINOLTA HOLDINGS, INC. (JP) 2008-08-28 US disclosed
EP-1950607-A1 DISPLAY ELEMENT AND PROCESS FOR PRODUCING THE SAME KONICA MINOLTA HOLDINGS, INC. (JP) 2008-07-30 EP disclosed
EP-1914225-A1 SALT MOLTEN AT ROOM TEMPERATURE AND DISPLAY DEVICE KONICA MINOLTA HOLDINGS, INC. (JP) 2008-04-23 EP disclosed
EP-1887418-A1 DISPLAY ELEMENT KONICA MINOLTA HOLDINGS, INC. (JP) 2008-02-13 EP disclosed
US-20060027783-A1 Displaying medium KONICA MINOLTA HOLDINGS, INC. (JP) 2006-02-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090091234-A1 ROOM TEMPERATURE MOLTEN SALT AND DISPLAY ELEMENT SAV1, TYR, MPST MEN1 42/4885KMT2A 700/4885KDM4E 3569/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.